We value strategic partnerships. Like our partnership with Celltrion for the launch of two biosimilars in North America in 2020.
And our exclusive partnership with Alvotech for the commercialization of five biosimilar product candidates in the
United States. Together, we’re working to build value in a number of therapeutic areas.